5-1-(imidazol)methyl-3,3-disubstituted-2(3h)furanone derivatives
CA 2030396 C · Owner: Hmr Pharma Inc. · Inventors: Spagnuolo, Ciro Jerry; Kaiser, Carl
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Furanone compounds and compositions having anticholinergic activity are described. The compounds have the formula:, wherein:, the dashed line indicates either the 4,5-unsaturated or the 4,5-dihydrofuranone ring;, R1 and R2 may be the same or different and are hydrogen, thienyl, furanyl, or cycloalkyl (C3-C6) benzyl, phenyl, substituted phenyl or substituted benzyl wherein the phenyl or benzyl group may be substituted with halogen trifluoromethyl, lower alkyl, lower alkoxy or hydroxy; R3, R4 and R5 may be the same or different and are hydrogen, lower alkyl, lower alkyl substituted with a halogen, alkoxy, amino or carboxylic acid group an alkyl or, alkylene bridge between R4 and R5 or R3 and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 20, 1990 and granted February 25, 1997. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 20, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 20, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.